Key immune cell cytokines have a significant role in the expansion of CD26 population of cord blood mononuclear cells
Source abstract
Abstract
BACKGROUND: Umbilical cord blood expresses cluster of differentiation (CD) 26, a fraction of CD34 + cells, negatively regulating in vivo homing and engraftment of hematopoietic stem cells. CD26 is highly expressed in various cells such as HSCs, immune cells, fibroblasts, and epithelial cells. It has been shown that inhibition of the CD26 on CD34 + cells improve the efficiency of transplantation of hematopoietic stem and progenitor cells. This study aimed to investigate the effect of key immune cell cytokines on CD26 expansion. MATERIAL AND METHODS: Cord blood mononuclear cells were cultured for 21 days using the stem cell factor, fetal liver tyrosine kinase 3 (Flt3) ligand (FL), interleukin (IL) 2, IL7, and IL15. Harvested cells were analyzed by flow cytometry at distinct time points. RESULTS: Our results showed that utilization of IL7 significantly improved the expression of total CD26 + cells (8.6-fold higher). When either IL2 or IL15 were added to the culture, the expression also improved 2.5-fold. The IL2 and IL7 showed significant effect on the expansion of both the CD26 + and CD26 fractions of the CD34 + cells. However, the effects of IL15 on CD26 + and CD26 -expansion were similar. CONCLUSION: Taken together, our data suggested that using IL7 causes higher proliferation of CD26 cells in comparison to that seen under other culture conditions.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Peptidase Inhibition and Analysis · Lung Cancer Research Studies · Proteoglycans and glycosaminoglycans research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
Tissue Engineering Research Group, Advanced Research School, Tabriz University of Medical Sciences, Tabriz, Iran
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
References (49)
Show source-provided references
1. 10.1182/blood.V98.7.225610.1182/blood.V98.7.2256 ↗
2. 10.1182/blood-2012-09-45523810.1182/blood-2012-09-455238 ↗
3. 10.1089/scd.2009.009810.1089/scd.2009.0098 ↗
4. 10.1089/scd.2007.999510.1089/scd.2007.9995 ↗
5. 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-710.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7 ↗
6. 10.1182/blood.V88.10.3901.bloodjournal8810390110.1182/blood.V88.10.3901.bloodjournal88103901 ↗
7. 10.4049/jimmunol.182.3.146010.4049/jimmunol.182.3.1460 ↗
8. 10.1126/science.109707110.1126/science.1097071 ↗
9. 10.1089/scd.2007.999610.1089/scd.2007.9996 ↗
10. 10.1182/blood-2002-12-389310.1182/blood-2002-12-3893 ↗
11. 10.1016/j.exphem.2012.07.00910.1016/j.exphem.2012.07.009 ↗
12. 10.4049/jimmunol.169.12.700010.4049/jimmunol.169.12.7000 ↗
13. 10.1016/S0171-2985(97)80084-810.1016/S0171-2985(97)80084-8 ↗
14. 10.1586/ehm.10.2410.1586/ehm.10.24 ↗
15. 10.2337/dc07-022810.2337/dc07-0228 ↗
16. 10.1016/j.imbio.2011.01.00510.1016/j.imbio.2011.01.005 ↗
17. 10.1182/blood.V99.11.389210.1182/blood.V99.11.3892 ↗
18. 10.1038/sj.bmt.170553810.1038/sj.bmt.1705538 ↗
19. Kahne T · Int J Mol Med · 1999 · 4 · 3
20. 10.4061/2011/27619310.4061/2011/276193 ↗
21. 10.4049/jimmunol.175.3.173510.4049/jimmunol.175.3.1735 ↗
22. Li Y · Anticancer Res · 2010 · 30 · 3493
23. 10.1182/blood.V81.12.3252.325210.1182/blood.V81.12.3252.3252 ↗
24. 10.1155/2011/86192010.1155/2011/861920 ↗
25. 10.1098/rsob.11003610.1098/rsob.110036 ↗
26. 10.1016/S0171-2985(00)80058-310.1016/S0171-2985(00)80058-3 ↗
27. 10.1182/blood-2009-10-24713010.1182/blood-2009-10-247130 ↗
28. 10.1182/asheducation.V2012.1.215.379829110.1182/asheducation.V2012.1.215.3798291 ↗
29. 10.4049/jimmunol.080048910.4049/jimmunol.0800489 ↗
30. 10.1093/annonc/mdp34210.1093/annonc/mdp342 ↗
31. 10.1073/pnas.053548210010.1073/pnas.0535482100 ↗
32. 10.1182/blood-2002-11-339210.1182/blood-2002-11-3392 ↗
33. 10.1002/stem.77010.1002/stem.770 ↗
34. Ren Z · J Blood Disorders Transf · 2013 · 3 · 2
35. 10.1006/cyto.1999.064310.1006/cyto.1999.0643 ↗
36. 10.1016/j.cyto.2008.03.00110.1016/j.cyto.2008.03.001 ↗
37. 10.1084/jem.2003115210.1084/jem.20031152 ↗
38. 10.1182/blood-2006-10-05472610.1182/blood-2006-10-054726 ↗
39. 10.1172/JCI858310.1172/JCI8583 ↗
40. Vanham G · J Acquir Immune Defic Syndr · 1993 · 6 · 749
41. 10.1073/pnas.93.4.145310.1073/pnas.93.4.1453 ↗
42. 10.4049/jimmunol.174.3.121310.4049/jimmunol.174.3.1213 ↗
43. 10.1016/j.coi.2005.01.00510.1016/j.coi.2005.01.005 ↗
44. 10.1016/S0140-6736(95)91268-110.1016/S0140-6736(95)91268-1 ↗
45. 10.1182/blood-2002-01-029410.1182/blood-2002-01-0294 ↗
46. 10.1038/nri190110.1038/nri1901 ↗
47. 10.1046/j.1537-2995.2001.41020213.x10.1046/j.1537-2995.2001.41020213.x ↗
48. 10.1111/j.1742-4658.2006.05253.x10.1111/j.1742-4658.2006.05253.x ↗
49. 10.1073/pnas.110031910810.1073/pnas.1100319108 ↗